Pulmonary Inflammation
5 clinical trials · Condition
◉ Watch Pulmonary Inflammation
| Record | Firm | Date |
|---|---|---|
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). (NCT04433546) | PhaseBio Pharmaceuticals Inc. | 2020-07-15 |
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis (NCT03309358) | Synspira, Inc. | 2017-09-28 |
| Pulmonary and Systemic Effects of Exposure to Wood Smoke (NCT03302117) | Umeå University | 2017-06-14 |
| Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis (NCT01837355) | Cantonal Hospital of St. Gallen | 2013-02-22 |
| Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 (NCT01748838) | Celtaxsys, Inc. | 2012-12-01 |
Track Pulmonary Inflammation automatically
Every clearance here is in the API, with alerts when new ones post.